gut
ME
ta
G
enome
A
tlas
Home
Browse
Search
Download
Help
About
Citation
LZX Lab
Introduction
Databases
dbEBV
dbRicePro
gutMEGA
iHypoxia
iCysMod
qPhos
qPTM
Tools
cPhosBac
DeepCalpain
DeepGSH
Deep-PLA
DrugCVar
dSCOPE
pCysMod
prkC-PSP
Result
taxon like '%o__Burkholderiales%'
Search content: Taxon = Burkholderiales
There are 2471 entries with your keyword(s).
Condition
1 year, Sensitized / Non-Sensitized
10-19 years / 4-9 years
10-19 years / Preweaning
10-19 years / Weaned-3 years
10-19 years / Weaning
20-29 years / 10-19 years
20-29 years / 4-9 years
20-29 years / Preweaning
20-29 years / Weaned-3 years
20-29 years / Weaning
30-39 years / 10-19 years
30-39 years / 20-29 years
30-39 years / 4-9 years
30-39 years / Preweaning
30-39 years / Weaned-3 years
30-39 years / Weaning
4-9 years / Preweaning
4-9 years / Weaned-3 years
4-9 years / Weaning
40-49 years / 10-19 years
40-49 years / 20-29 years
40-49 years / 30-39 years
40-49 years / 4-9 years
40-49 years / Preweaning
40-49 years / Weaned-3 years
40-49 years / Weaning
50-59 years / 10-19 years
50-59 years / 20-29 years
50-59 years / 30-39 years
50-59 years / 4-9 years
50-59 years / 40-49 years
50-59 years / Preweaning
50-59 years / Weaned-3 years
50-59 years / Weaning
60-69 years / 10-19 years
60-69 years / 20-29 years
60-69 years / 30-39 years
60-69 years / 4-9 years
60-69 years / 40-49 years
60-69 years / 50-59 years
60-69 years / Preweaning
60-69 years / Weaned-3 years
60-69 years / Weaning
70-79 years / 10-19 years
70-79 years / 20-29 years
70-79 years / 30-39 years
70-79 years / 4-9 years
70-79 years / 40-49 years
70-79 years / 50-59 years
70-79 years / 60-69 years
70-79 years / Preweaning
70-79 years / Weaned-3 years
70-79 years / Weaning
80-89 years / 10-19 years
80-89 years / 20-29 years
80-89 years / 30-39 years
80-89 years / 4-9 years
80-89 years / 40-49 years
80-89 years / 50-59 years
80-89 years / 60-69 years
80-89 years / 70-79 years
80-89 years / Preweaning
80-89 years / Weaned-3 years
80-89 years / Weaning
90-99 years / 10-19 years
90-99 years / 20-29 years
90-99 years / 30-39 years
90-99 years / 4-9 years
90-99 years / 40-49 years
90-99 years / 50-59 years
90-99 years / 60-69 years
90-99 years / 70-79 years
90-99 years / 80-89 years
90-99 years / Preweaning
90-99 years / Weaned-3 years
90-99 years / Weaning
> 100 years / 10-19 years
> 100 years / 20-29 years
> 100 years / 30-39 years
> 100 years / 4-9 years
> 100 years / 40-49 years
> 100 years / 50-59 years
> 100 years / 60-69 years
> 100 years / 70-79 years
> 100 years / 80-89 years
> 100 years / 90-99 years
> 100 years / Preweaning
> 100 years / Weaned-3 years
> 100 years / Weaning
Adenomas / Normal
Adult control / Pediatric control
Advanced conventional adenoma / Normal
Alcoholic liver disease / Alcohol dependence syndrome
Amerindians / Malawi
Amyotrophic lateral sclerosis / Normal
Animal-based diet / Plant-based diet
Anti-islet cell autoantibodies, Developed / Remained negative
Antibiotics, No exposure / Chronic exposure
Any breast-fed children, Mother secretor / Mother non-secretor
Asymptomatic C. difficile carriers / C. difficile infection
Asymptomatic C. difficile carriers / Normal
Atherosclerotic cardiovascular disease / Normal
Atrial fibrillation / No atrial fibrillation
Autism / Normal
Autism / Pervasive developmental disorder not otherwise specified
Autistic / Neurotypical
Bai / Han
Beta2-1 fructan / Placebo
Bipolar disorder / Normal
Blend of corn/safflower oil / Conventional canola oil
Blend of corn/safflower oil / DHA-enriched high oleic canola oil
Blend of flax/safflower oil / Blend of corn/safflower oil
Blend of flax/safflower oil / Conventional canola oil
Blend of flax/safflower oil / DHA-enriched high oleic canola oil
Breast-fed / Placebo formula
C. difficile infection / Donor
C. difficile infection / Normal
C. difficile infection patient 1, 11 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 11 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 11 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 11 days post-FTM / Donor
C. difficile infection patient 1, 128 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 25 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 128 days post-FTM / 65 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / 95 days post-FTM
C. difficile infection patient 1, 128 days post-FTM / Donor
C. difficile infection patient 1, 18 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 18 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 18 days post-FTM / Donor
C. difficile infection patient 1, 25 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 25 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 25 days post-FTM / Donor
C. difficile infection patient 1, 3 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 3 days post-FTM / Donor
C. difficile infection patient 1, 3 days pre-FTM / Donor
C. difficile infection patient 1, 65 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 25 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 65 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 65 days post-FTM / Donor
C. difficile infection patient 1, 7 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 7 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 7 days post-FTM / Donor
C. difficile infection patient 1, 95 days post-FTM / 11 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 18 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 25 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 3 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 3 days pre-FTM
C. difficile infection patient 1, 95 days post-FTM / 65 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / 7 days post-FTM
C. difficile infection patient 1, 95 days post-FTM / Donor
C. difficile infection patient 2, 1 days pre-FTM / Donor
C. difficile infection patient 2, 112 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 112 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 41 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / 81 days post-FTM
C. difficile infection patient 2, 112 days post-FTM / Donor
C. difficile infection patient 2, 27 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 27 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 27 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 27 days post-FTM / Donor
C. difficile infection patient 2, 3 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 3 days post-FTM / Donor
C. difficile infection patient 2, 41 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 41 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 41 days post-FTM / Donor
C. difficile infection patient 2, 7 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 7 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 7 days post-FTM / Donor
C. difficile infection patient 2, 81 days post-FTM / 1 days pre-FTM
C. difficile infection patient 2, 81 days post-FTM / 27 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / 3 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / 41 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / 7 days post-FTM
C. difficile infection patient 2, 81 days post-FTM / Donor
C. difficile infection patient 3, 13 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 13 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 13 days post-FTM / Donor
C. difficile infection patient 3, 15 days pre-FTM / Donor
C. difficile infection patient 3, 20 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 20 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 20 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 20 days post-FTM / Donor
C. difficile infection patient 3, 28 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 28 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 28 days post-FTM / Donor
C. difficile infection patient 3, 36 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 36 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 36 days post-FTM / Donor
C. difficile infection patient 3, 68 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 68 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 36 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 68 days post-FTM / Donor
C. difficile infection patient 3, 7 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 7 days post-FTM / Donor
C. difficile infection patient 3, 90 days post-FTM / 13 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 15 days pre-FTM
C. difficile infection patient 3, 90 days post-FTM / 20 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 28 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 36 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 68 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / 7 days post-FTM
C. difficile infection patient 3, 90 days post-FTM / Donor
C. difficile infection, Recurrent / Nonrecurrent
C. difficile infection, Reinfection / Nonrecurrent
Caesarean section, Full-term / Pre-term
Caserones-Chile / Hinds Cave-USA
Children with PZQ, 1.1-2 years / 0-1 years
Children with PZQ, 10.1-13 years / 0-1 years
Children with PZQ, 10.1-13 years / 3.1-4 years
Children with PZQ, 10.1-13 years / 4.1-5 years
Children with PZQ, 10.1-13 years / 7.1-8 years
Children with PZQ, 2.1-3 years / 0-1 years
Children with PZQ, 3.1-4 years / 0-1 years
Children with PZQ, 3.1-4 years / 1.1-2 years
Children with PZQ, 3.1-4 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 0-1 years
Children with PZQ, 4.1-5 years / 1.1-2 years
Children with PZQ, 4.1-5 years / 2.1-3 years
Children with PZQ, 4.1-5 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 0-1 years
Children with PZQ, 5.1-6 years / 3.1-4 years
Children with PZQ, 5.1-6 years / 4.1-5 years
Children with PZQ, 6.1-7 years / 0-1 years
Children with PZQ, 6.1-7 years / 3.1-4 years
Children with PZQ, 6.1-7 years / 4.1-5 years
Children with PZQ, 7.1-8 years / 0-1 years
Children with PZQ, 7.1-8 years / 1.1-2 years
Children with PZQ, 7.1-8 years / 2.1-3 years
Children with PZQ, 7.1-8 years / 3.1-4 years
Children with PZQ, 7.1-8 years / 4.1-5 years
Children with PZQ, 7.1-8 years / 5.1-6 years
Children with PZQ, 7.1-8 years / 6.1-7 years
Children with PZQ, 8.1-9 years / 0-1 years
Children with PZQ, 8.1-9 years / 3.1-4 years
Children with PZQ, 8.1-9 years / 4.1-5 years
Children with PZQ, 8.1-9 years / 7.1-8 years
Children with PZQ, 9.1-10 years / 0-1 years
Children with PZQ, 9.1-10 years / 3.1-4 years
Children with PZQ, 9.1-10 years / 4.1-5 years
Children with PZQ, 9.1-10 years / 7.1-8 years
Children, Mother secretor / Mother non-secretor
Children, Secretor / Non-secretor
China / Korea
China, After 2 weeks / Baseline
China, Urban / Rural
Chinese Han living in Shaanxi province / Tibetans
Chinese Han living in Tibet / Chinese Han living in Shaanxi province
Chinese Han living in Tibet / Tibetans
Chronic periodontitis / Gingivitis
Chronic periodontitis / Periodontal health
Chubu / Hokkaido
Chubu / Kanto
Chubu / Tohoku
Chugoku Shikoku / Chubu
Chugoku Shikoku / Hokkaido
Chugoku Shikoku / Kansai
Chugoku Shikoku / Kanto
Chugoku Shikoku / Tohoku
Clostridia phase / Bacilli phase
Clostridia phase / Gammaproteobacteria phase
Collected in the inner / Collected in the outer
Colon polyps / Normal
Colorectal adenoma / Normal
Colorectal cancer / Colorectal adenoma
Colorectal cancer / Normal
Consensus molecular subtypes 2 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 1
Consensus molecular subtypes 3 / Consensus molecular subtypes 2
Constipated / Normal
Constipated after lubiprostone / Normal
Constipated before lubiprostone / Normal
Constipation / Normal
Conventional adenoma / Normal
Coronary artery disease / Normal
Crohn's disease / Normal
Crohn's disease / Ulcerative colitis
Crohn's disease 6 months, remission / recurrence
Crohn's disease Active / Normal
Crohn's disease active onset / Normal
Crohn's disease Active presurgery / Normal
Crohn's disease induction of remission treatments, Responders / Non-responders
Crohn's disease recurrence, 6 months / 0 month
Crohn's disease remission, 6 months / 0 month
Crohn's disease severe / Normal
Crohn's disease, Active / Active onset
Crohn's disease, Active presurgery / Active
Crohn's disease, Active presurgery / Active onset
Crohn's disease, FUT2+/- / FUT2+/+
Crohn's disease, FUT2-/- / FUT2+/+
Crohn's disease, FUT2-/- / FUT2+/-
Cystic fibrosis / Normal
Day Hospital / Community
DHA-enriched high oleic canola oil / Conventional canola oil
Diarrheal Phase 2 / Diarrheal Phase 1
Diarrheal Phase 3 / Diarrheal Phase 1
Diarrheal Phase 4 / Diarrheal Phase 1
Distal conventional adenoma / Normal
During the first ciprofloxacin course / Before ciprofloxacin
During the first week post-first ciprofloxacin / Before ciprofloxacin
During the first week post-second ciprofloxacin / Before ciprofloxacin
During the second ciprofloxacin course / Before ciprofloxacin
Exclusively breast-fed children, Mother secretor / Mother non-secretor
Fecal / Mucosal
Female / Male
Formula-fed infants / Breast-fed infants
Full-term, Caesarean section / Spontaneous vaginally delivered
Gammaproteobacteria phase / Bacilli phase
Gingivitis / Periodontal health
Gonadotropin-releasing hormone / No androgen derivation therapy
Habitual diet+Resistant starch / Habitual diet
Hepatic encephalopathy / Normal
High gene count / Low gene count
High oleic canola oil / Conventional canola oil
High oleic canola oil / DHA-enriched high oleic canola oil
HIV, CD4 > 200 / CD4 < 200
HIV, Men sex with men / Non-men sex with men
HIV, Negative / CD4 < 200
Hodgkin lymphoma / Normal
Homogenised / Collected in the outer
Human Microbiome Project participants / Korean twins
Hyperplastic polyp / Normal
Idiopathic rapid eye movement sleep behavior disorder / Normal
Idiopathic rapid eye movement sleep behavior disorder / Parkinson's disease
In the interim period between ciprofloxacin courses / Before ciprofloxacin
Infant 1 month / Mother 1 week prior to delivery
Infant 1 week / Mother 1 week prior to delivery
Infant 1 year / Mother 1 week prior to delivery
Infant 3 months / Mother 1 week prior to delivery
Infant 7 months / Mother 1 week prior to delivery
Inflammatory bowel disease / Normal
Ingestion of flaxseeds, 1 week post-intervention / Start
Ingestion of flaxseeds, Immediately after intervention / Start
Inpatient / Pediatric control
Intervention formula / Placebo formula
Intrapartum antibiotic prophylaxis / Control
Irritable bowel syndrome, After treatment / Before treatment
Japan / China
Japan / Korea
Japan / USA
Juvenile idiopathic arthritis / Normal
Kansai / Chubu
Kansai / Hokkaido
Kansai / Kanto
Kansai / Tohoku
Kanto / Hokkaido
Kanto / Tohoku
Kazakh / Bai
Kazakh / Han
Kazakh / Zhuang
Kyushu / Chubu
Kyushu / Chugoku Shikoku
Kyushu / Hokkaido
Kyushu / Kansai
Kyushu / Kanto
Kyushu / Tohoku
Lactobacillus casei Zhang, 28 days / 0 day
Lactobacillus casei Zhang, 42 days / 0 day
Lactobacillus casei Zhang, 42 days / 28 days
Long-stay / Community
Long-stay / Day Hospital
Long-stay / Rehabilitation
Madagascar / Central African Republic
Male / Female
Mongol / Bai
Mongol / Han
Mongol / Kazakh
Mongol / Uyghur
Mongol / Zhuang
Mother 1 year after delivery / Mother 1 week prior to delivery
Multiple kidney stones / Normal
Multiple sclerosis / Normal
Multiple sclerosis treated / Normal
Multiple sclerosis untreated / Normal
Necrotizing enterocolitis / Normal
Neurotypical / Autism spectrum disorder
Nizatidine / Control
Non-advanced conventional adenoma / Normal
Non-alcoholic fatty liver disease / Normal
Non-alcoholic fatty liver disease, 0-1 fibrosis / > 1 fibrosis
Nonalcoholic steatohepatitis / Normal
Nonalcoholic steatohepatitis / Obese
Nonsteroidal antiinflammatory drug / Control
Obese / Normal
Obese patients underwent Roux-en-Y gastric bypass, 1 year / Baseline
Obese patients underwent Roux-en-Y gastric bypass, 3 months / Baseline
Oral androgen receptor axis-targeted therapies / Gonadotropin-releasing hormone
Oral androgen receptor axis-targeted therapies / No androgen derivation therapy
Other colorectal conditions / Colorectal adenoma
Other colorectal conditions / Normal
Outpatient / Pediatric control
Parkinson's disease / Normal
Past azithromycin 0 day / Normal
Past azithromycin 1 day / Normal
Past azithromycin 1 month / Normal
Past azithromycin 1 week / Normal
Past azithromycin, 1 day / 0 day
Past azithromycin, 1 month / 0 day
Past azithromycin, 1 month / 1 day
Past azithromycin, 1 month / 1 week
Past azithromycin, 1 week / 0 day
Past azithromycin, 1 week / 1 day
Pervasive developmental disorder not otherwise specified / Normal
Post ciprofloxacin / Before ciprofloxacin
Post-exclusive enteral nutrition / Pre-exclusive enteral nutrition
Postmenopausal breast cancer / Normal
Premenopausal breast cancer / Normal
Probiotic administration 4 weeks / Baseline
Probiotics / Placebo
Proximal conventional adenoma / Normal
Recovery Phase 2 / Recovery Phase 1
Recovery Phase 3 / Recovery Phase 1
Rectal cancer / Normal
Rehabilitation / Community
Rehabilitation / Day Hospital
Rett syndrome / Normal
Rheumatoid arthritis / Normal
Rio Zape-Mexico / Hinds Cave-USA
Schistosomiasis, Positive / Negative
Sessile serrated adenoma / Normal
Severely stunted / Moderately stunted
Stopping the probiotic intake 4 weeks / Probiotic administration 4 weeks
Stunted / Nonstunted
Summer / Winter
SunGold kiwifruit, 12 weeks / Baseline
SunGold kiwifruit, 6 weeks / Baseline
Tibetan / Bai
Tibetan / Han
Tibetan / Kazakh
Tibetan / Mongol
Tibetan / Uyghur
Tibetan / Zhuang
Tohoku / Hokkaido
TUW / Khentii
Type 1 diabetes / Normal
Type 1 diabetes after 2 years treatment / Normal
Type 1 diabetes after 2 years treatment / Type 1 diabetes at onset
Type 1 diabetes at onset / Normal
Ulan Bator / Khentii
Ulan Bator / TUW
Ulcerative colitis / Normal
Ulcerative colitis with FMT / Donor
Urban Mongolian / Rural Mongolian
USA / Amerindians
USA / China
USA / Korea
USA / Malawi
UTI patients, Adult household / Control
UTI patients, Ciprofloxacin / Control
UTI patients, Fosfomycin / Control
UTI patients, Nitrofurantoin / Control
Uyghur / Bai
Uyghur / Han
Uyghur / Kazakh
Uyghur / Zhuang
Weaned-3 years / Preweaning
Weaned-3 years / Weaning
Women with previous gestational diabetes / Normal
Zhuang / Bai
Zhuang / Han
Taxon level
Family
Genus
No rank
Order
Species
Log2Ratio
>
=
<
Filter
Download
Detail
Taxon
Condition
Log2Ratio
P
value
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales
HIV, CD4 > 200 / CD4 < 200
-3.72541139
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales
Summer / Winter
0.788
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__; g__; s__Burkholderiales bacterium 1_1_47
Colorectal cancer / Colorectal adenoma
2.38
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__; g__; s__Burkholderiales bacterium 1_1_47
Colorectal cancer / Normal
4.635
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__; g__; s__Burkholderiales bacterium 1_1_47
Rheumatoid arthritis / Normal
0.95
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__; g__Aquabacterium
Adenomas / Normal
1.58
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__Alcaligenaceae
Proximal conventional adenoma / Normal
0.526068812
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__Alcaligenaceae; g__Achromobacter
Rectal cancer / Normal
-0.82
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__Alcaligenaceae; g__Alcaligenes; s__Alcaligenes faecalis
Type 1 diabetes / Normal
3.526
<0.001
Loading...
k__Bacteria; p__Proteobacteria; c__Betaproteobacteria; o__Burkholderiales; f__Alcaligenaceae; g__Derxia
Summer / Winter
2.555
<0.001
Loading...
Showing 1 to 10 of 2471 entries
,
10
20
50
100
entries per page
<
1
2
3
4
5
...
248
>
